The Stress Responses of Fetuses and Infants Whose Mothers Smoked During Pregnancy
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It is generally understood that smoking during pregnancy has deleterious effects on the developing fetus, although research on smoking during pregnancy has been limited in focus, with most studies focused on birth weight of newborns and children's behavioral disturbances. However, little is known about the neurobiological underpinnings of nicotine-related developmental deficits and even less is known about genetic and environmental factors that may exacerbate the risk for such deficits in some children. In this study, we propose to examine the relation between antenatal exposure to nicotine and infants' stress-responses before and after birth (2-days, 6-months) and its moderation of by family-based stressors and genes related to nicotine metabolism and stress responsivity.
We hypothesize that the risk imposed on infants by antenatal exposure to nicotine is moderated by genotype that influences functioning of the HPA axis, metabolism of nicotine, and stress-levels and parenting that influence the development of neural substrates (HPA axis) and infants' capacity to cope with stress. There is a growing consensus that Gene x Environmental (G x E) interplay likely mediated by epigenetic effects constitute one of the central mechanism by which complex disorders develop. Our proposal offers an exceptional paradigm to explore the association between genes, environment, and G x E interactions on the neural and behavior response of children to stressful challenges.
| Condition |
|---|
|
Effects of Smoking on Infant |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Prospective |
| Official Title: | The Stress Responses of Fetuses and Infants Whose Mothers Smoked During Pregnancy: Genes, Hormones and Psychological Modulators |
DNA samples + salivery cortisol
| Estimated Enrollment: | 200 |
| Study Start Date: | April 2008 |
| Estimated Study Completion Date: | December 2008 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 22 Years to 35 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Women who smoked during pregnancy
Inclusion Criteria:
- Smokes at least 10 cigarettes a day
- No abuse of alcohol or drugs
- No chronic physical disability
- 22-35 years of age
- Living with partner
- Speaks English, Hebrew, or Russian
- Natural conception
Contacts and Locations| Contact: David Mankuta, MD | 97226776484 | mankutad@gmail.com |
| Israel | |
| Hadassah Medical Organization | Recruiting |
| Jerusalem, Israel | |
| Contact: David Mankuta, MD | |
| Sub-Investigator: Rachel Bachner, PhD | |
| Study Chair: | Ebstein Richard, MD PhD | Hebrew University Jerusalem Israel |
More Information
No publications provided
| Responsible Party: | David Mankuta, Hadassah |
| ClinicalTrials.gov Identifier: | NCT00563966 History of Changes |
| Other Study ID Numbers: | smokingmothers-HMO-CTIL |
| Study First Received: | November 25, 2007 |
| Last Updated: | May 9, 2008 |
| Health Authority: | Israel: Ministry of Health |
Keywords provided by Hadassah Medical Organization:
|
smoking pregnancy behaviour polymorphisms |
Additional relevant MeSH terms:
|
Smoking Habits |
ClinicalTrials.gov processed this record on May 23, 2013